Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali

Laree Tracy, Holly D. Gaff, Colleen Burgess, Samba Sow, Patti E. Gravitt, J. Kathleen Tracy

Research output: Contribution to journalArticle

Abstract

Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.

Original languageEnglish (US)
Pages (from-to)641-645
Number of pages5
JournalClinical Infectious Diseases
Volume52
Issue number5
DOIs
StatePublished - Mar 1 2011

Fingerprint

Mali
Papillomavirus Vaccines
Papillomavirus Infections
Uterine Cervical Neoplasms
Developing Countries
Vaccination
Vaccines
Economics
Mortality
Incidence

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. / Tracy, Laree; Gaff, Holly D.; Burgess, Colleen; Sow, Samba; Gravitt, Patti E.; Tracy, J. Kathleen.

In: Clinical Infectious Diseases, Vol. 52, No. 5, 01.03.2011, p. 641-645.

Research output: Contribution to journalArticle

Tracy, Laree ; Gaff, Holly D. ; Burgess, Colleen ; Sow, Samba ; Gravitt, Patti E. ; Tracy, J. Kathleen. / Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali. In: Clinical Infectious Diseases. 2011 ; Vol. 52, No. 5. pp. 641-645.
@article{9325839f2322481c8f02ac2d3462da95,
title = "Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali",
abstract = "Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.",
author = "Laree Tracy and Gaff, {Holly D.} and Colleen Burgess and Samba Sow and Gravitt, {Patti E.} and Tracy, {J. Kathleen}",
year = "2011",
month = "3",
day = "1",
doi = "10.1093/cid/ciq190",
language = "English (US)",
volume = "52",
pages = "641--645",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Estimating the impact of Human papillomavirus (HPV) vaccination on HPV prevalence and cervical cancer incidence in Mali

AU - Tracy, Laree

AU - Gaff, Holly D.

AU - Burgess, Colleen

AU - Sow, Samba

AU - Gravitt, Patti E.

AU - Tracy, J. Kathleen

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.

AB - Human papillomavirus vaccines have potential to reduce cervical cancer incidence and mortality; however, cultural and economic barriers may hinder success in developing countries. We assessed impact of a single vaccine campaign in Mali with use of mathematical modeling. Our model shows that decreases in the prevalence of Human papillomavirus infection are proportional to achieved vaccination coverage.

UR - http://www.scopus.com/inward/record.url?scp=79951832979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951832979&partnerID=8YFLogxK

U2 - 10.1093/cid/ciq190

DO - 10.1093/cid/ciq190

M3 - Article

VL - 52

SP - 641

EP - 645

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -